2021-12-23

Contemporary OB/GYN: Not all HPV genotypes pose the same risk for disease

Contemporary Obgyn: Not all HPV genotypes pose the same risk for disease

Why do HPV tests with extended genotyping provide a more personalized assessment of an individual’s risk for developing cervical precancer? Discover the perspective of Molly Broache, Senior Manager, Medical Science Liaison at BD Life Sciences.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

BD submits pre-market approval supplement to FDA to enable ThinPrep® Pap Test™ PreservCyt® Solution to be used with the BD Onclarity™ HPV Assay
Cervical Cancer | News & Updates
Press release: BD submits pre-market approval supplement to FDA to enable ThinPrep® Pap Test™ PreservCyt® Solution to be used with the BD Onclarity™ HPV Assay
Contemporary OB/GYN: BD Onclarity™ HPV Assay: What it means for the future of cervical cancer detection
Cervical Cancer | News & Updates
Contemporary OB/GYN: BD Onclarity™ HPV Assay: What it means for the future of cervical cancer detection
ROI-NJ: BD’s new Onclarity HPV test greatly improves standard of care for women
Cervical Cancer | News & Updates
ROI-NJ: BD’s new Onclarity HPV test greatly improves standard of care for women